共 50 条
Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton
被引:17
|作者:
Sakai, Taki
[1
]
Matsumoto, Yotaro
[1
]
Ishikawa, Minoru
[1
]
Sugita, Kazuyuki
[1
]
Hashimoto, Yuichi
[1
]
Wakai, Nobuhiko
[2
]
Kitao, Akio
[2
]
Morishita, Era
[3
]
Toyoshima, Chikashi
[3
]
Hayashi, Tomoatsu
[4
]
Akiyama, Tetsu
[4
]
机构:
[1] Univ Tokyo, Inst Mol & Cellular Biosci, Bioorgan Chem Lab, Bunkyo Ku, Tokyo 1130032, Japan
[2] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Computat Prot Sci, Bunkyo Ku, Tokyo 1130032, Japan
[3] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Membrane Prot, Bunkyo Ku, Tokyo 1130032, Japan
[4] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo 1130032, Japan
关键词:
Sirtuin;
SIRT2;
HISTONE DEACETYLASE;
PROTEIN;
DEHYDROGENASE;
REGULATOR;
LONGEVITY;
INTERACTS;
HOMOLOG;
D O I:
10.1016/j.bmc.2014.11.027
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Human sirtuin 2 (SIRT2) is an attractive target molecule for development of drugs to treat neurodegenerative diseases and cancer, because SIRT2 inhibitors have a protective effect against neurodegeneration and an anti-proliferative effect on cancer stem cells. We designed and synthesized a series of benzamide derivatives as SIRT2 inhibitor candidates. Among them, compound 17k showed the most potent SIRT2-inhibitory activity (IC50 = 0.60 mu M), with more than 150-fold selectivity over SIRT1 and SIRT3 isoforms (IC50 > 100 mu M). (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:328 / 339
页数:12
相关论文